Business
Why the Immuron (ASX:IMC) share price is rocketing up 10% today
The Immuron Ltd (ASX: IMC) share price is surging today following a research agreement with Monash University for combating COVID-19. At the time of writing, the Immuron share price is up 10.42% to 26.5 cents.
Immuron is clinical-stage biopharmaceutical company focused on the development and commercialisation of a novel class of specifically targeted polyclonal antibodies. The company researches and develops hyperimmune products for markets in Australia, the United States and Canada.
Product sales comprise Travelan and Protectyn, which is used for the prevention of travellers’ diarrhoea.
What’s pushing the Immuron share price higher?
The Immuron share price has been a positive mover today compared to the broader All Ordinaries…
-
Noosa News18 hours agoBrisbane community mourns 14-year-old Declan Phillips after deadly Wynnum crash
-
General18 hours agoThe wrong way to respond to antisemitism • Inside Story
-
Business22 hours agoUp 29% since April, why is this ASX 200 coal stock tumbling today?
-
Business19 hours agoUp 55% this year, does Macquarie rate Gold Road Resources shares a buy, hold or sell?